BACKGROUND: Obesity is a major public health issue and is associated with increased risk of several cancers, currently a leading cause of mortality. Obese patients undergoing bariatric surgery may allow for evaluation of the effect of intentional excess weight loss on subsequent risk of cancer. We aimed to evaluate cancer risk, incidence, and mortality after bariatric surgery. METHODS: A comprehensive literature search was conducted using PubMed/MEDLINE and Embase with literature published from the inception of both databases to January 2012. Inclusion criteria incorporated all human studies examining oncologic outcomes after bariatric surgery. Two authors independently reviewed selected studies and relevant articles from their bibliographies for data extraction, quality appraisal, and meta-analysis. RESULTS: Six observational studies (n = 51,740) comparing relative risk (RR) of cancer in obese patients undergoing bariatric surgery versus obese control subjects were analyzed. Overall, the RR of cancer in obese patients after undergoing bariatric surgery was 0.55 [95% confidence interval (CI) 0.41-0.73, p < 0.0001, I(2) = 83%]. The effect of bariatric surgery on cancer risk was modified by gender (p = 0.021). The pooled RR in women was 0.68 (95% CI 0.60-0.77, p < 0.0001, I(2) < 0.1%) and in men was 0.99 (95% CI 0.74-1.32, p = 0.937, I(2) < 0.1%). CONCLUSIONS: Bariatric surgery reduces cancer risk and mortality in formerly obese patients. When stratifying the meta-analysis by gender, the effect of bariatric surgery on oncologic outcomes is protective in women but not in men.
BACKGROUND:Obesity is a major public health issue and is associated with increased risk of several cancers, currently a leading cause of mortality. Obesepatients undergoing bariatric surgery may allow for evaluation of the effect of intentional excess weight loss on subsequent risk of cancer. We aimed to evaluate cancer risk, incidence, and mortality after bariatric surgery. METHODS: A comprehensive literature search was conducted using PubMed/MEDLINE and Embase with literature published from the inception of both databases to January 2012. Inclusion criteria incorporated all human studies examining oncologic outcomes after bariatric surgery. Two authors independently reviewed selected studies and relevant articles from their bibliographies for data extraction, quality appraisal, and meta-analysis. RESULTS: Six observational studies (n = 51,740) comparing relative risk (RR) of cancer in obesepatients undergoing bariatric surgery versus obese control subjects were analyzed. Overall, the RR of cancer in obesepatients after undergoing bariatric surgery was 0.55 [95% confidence interval (CI) 0.41-0.73, p < 0.0001, I(2) = 83%]. The effect of bariatric surgery on cancer risk was modified by gender (p = 0.021). The pooled RR in women was 0.68 (95% CI 0.60-0.77, p < 0.0001, I(2) < 0.1%) and in men was 0.99 (95% CI 0.74-1.32, p = 0.937, I(2) < 0.1%). CONCLUSIONS: Bariatric surgery reduces cancer risk and mortality in formerly obesepatients. When stratifying the meta-analysis by gender, the effect of bariatric surgery on oncologic outcomes is protective in women but not in men.
Authors: D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker Journal: JAMA Date: 2000-04-19 Impact factor: 56.272
Authors: Ikuyo Imayama; Cornelia M Ulrich; Catherine M Alfano; Chiachi Wang; Liren Xiao; Mark H Wener; Kristin L Campbell; Catherine Duggan; Karen E Foster-Schubert; Angela Kong; Caitlin E Mason; Ching-Yun Wang; George L Blackburn; Carolyn E Bain; Henry J Thompson; Anne McTiernan Journal: Cancer Res Date: 2012-05-01 Impact factor: 12.701
Authors: David E Cummings; David S Weigle; R Scott Frayo; Patricia A Breen; Marina K Ma; E Patchen Dellinger; Jonathan Q Purnell Journal: N Engl J Med Date: 2002-05-23 Impact factor: 91.245
Authors: Ted D Adams; Antoinette M Stroup; Richard E Gress; Kenneth F Adams; Eugenia E Calle; Sherman C Smith; R Chad Halverson; Steven C Simper; Paul N Hopkins; Steven C Hunt Journal: Obesity (Silver Spring) Date: 2009-01-15 Impact factor: 5.002
Authors: Nicolas V Christou; John S Sampalis; Moishe Liberman; Didier Look; Stephane Auger; Alexander P H McLean; Lloyd D MacLean Journal: Ann Surg Date: 2004-09 Impact factor: 12.969
Authors: Mingyang Song; Frank B Hu; Donna Spiegelman; Andrew T Chan; Kana Wu; Shuji Ogino; Charles S Fuchs; Walter C Willett; Edward L Giovannucci Journal: Cancer Prev Res (Phila) Date: 2015-04-30
Authors: Federico Pietrocola; Jonathan Pol; Erika Vacchelli; Shuan Rao; David P Enot; Elisa E Baracco; Sarah Levesque; Francesca Castoldi; Nicolas Jacquelot; Takahiro Yamazaki; Laura Senovilla; Guillermo Marino; Fernando Aranda; Sylvère Durand; Valentina Sica; Alexis Chery; Sylvie Lachkar; Verena Sigl; Norma Bloy; Aitziber Buque; Simonetta Falzoni; Bernhard Ryffel; Lionel Apetoh; Francesco Di Virgilio; Frank Madeo; Maria Chiara Maiuri; Laurence Zitvogel; Beth Levine; Josef M Penninger; Guido Kroemer Journal: Cancer Cell Date: 2016-07-11 Impact factor: 31.743